Amitriptyline Hydrochloride Tablet
Product Images NDC 16571-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amitriptyline Hydrochloride (NDC 16571-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 01)

FDA Label Image

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 02)

FDA Label Image

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 03)

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 03)
The text provided is a description of a medication called Amitriptyline Hydrochloride. It is available in the form of tablets and is used for certain medical conditions. The typical dosage and storage instructions are mentioned. The medication should be dispensed with the provided Medication Guide, and it needs to be stored in a tightly sealed and light-resistant container. It is important to keep it out of the reach of children. The medication is manufactured by Gravitl Pharmaceuticals Pvt. Ltd., located in Telangana, India, and distributed by Rising Pharma Holdings, Inc. located in East Brunswick, NJ, USA. The expiration date mentioned is 05/2023.*
FDA Label Image

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 04)

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 04)
This is a description of a medication called Amitriptyline Hydrochloride Tablets, USP. Each tablet contains 50 mg of Amitriptyline Hydrochloride. The usual dosage information can be found in the package insert. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with permissible excursions between 10°C to 30°C (59°F to 86°F). It should be dispensed in a tight, light-resistant container and kept out of the reach of children. The medication is manufactured by Gravitl Pharmaceuticals Pvt. Ltd. in Telangana, India, and distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ, USA. The medication guide is available at the website provided.*
FDA Label Image

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 05)

FDA Label Image

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 06)

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 06)
This is a description of a medication called Amitriptyline Hydrochloride, which is available in tablet form. The tablets contain 100 mg of Amitriptyline Hydrochloride. The usual dosage is mentioned, along with the storage instructions. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F) with excursions permitted at 10° to 15°C to 30°C (59° to 86°F). The medication should be dispensed in a tight, light-resistant container and kept out of the reach of children. The medication guide is available separately and should be consulted by the pharmacist. The medication is manufactured by Gravitl Pharmaceuticals P, Ltd in Telangana, India, and distributed by Rising Pharma Holdings, Inc in East Brunswick, NJ. The expiration date of the medication is May 2023. Unfortunately, the remaining text is not readable.*
FDA Label Image

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 07)

Image (5df00dd1 32b6 4b08 8c7c 55a9c38cde5b 07)
This text appears to be the description and instructions for the medication "Amitriptyline Hydrochloride Tablets, USP." The tablets contain 150 mg of Amitriptyline Hydrochloride and are intended for usual dosage as described in the package insert. The medication should be stored at a temperature of 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The pharmacist should dispense the medication with the Medication Guide, which is available separately. The medication should be kept in a tight, light-resistant container and out of the reach of children. The medication is manufactured by Graviti Pharmaceuticals Pvt. Ltd. in India and distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ. The document is issued in October 2023.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.